New Study Finds U.S. Soybean Industry Has $115 Billion Impact on the American Economy

Mar 25, 2020

The National Oilseed Processors Association (NOPA), a trade association representing owners/operators of oilseed crush facilities, is pleased to announce the availability of a new study, The Economic Impact of the U.S. Soybeans & End Products on the U.S. Economy, that examines the value of the American soybean industry. NOPA partnered with the United Soybean Board (USB) in commissioning LMC International Ltd, an independent economic consulting firm that specializes in global agricultural commodity and agribusiness sectors, to develop the study.

This 31-page study analyzes the soybean value chain’s impact to the U.S. economy, based on data from crop years 2014/15 to 2016/17. As highlighted in the report summary, during this period:

The total economic impact on the U.S. economy from the soybean sector averaged $115.8 billion.
The soybean sector supported an average of 357,000 people, comprising 280,000 paid, full-time equivalent jobs as well as an additional 78,000 family members, beyond growers themselves, who support and are supported by soybean farming operations.
The total wage impact of the sector averaged $11.6 billion.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.